Federated Hermes, Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Federated Hermes, Inc.
- $42.5 Billion
- Q1 2024
A detailed history of Federated Hermes, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 4,695,372 shares of ARCT stock, worth $182 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
4,695,372
Previous 4,711,512
0.34%
Holding current value
$182 Million
Previous $149 Million
6.74%
% of portfolio
0.37%
Previous 0.37%
Shares
14 transactions
Others Institutions Holding ARCT
# of Institutions
195Shares Held
26.7MCall Options Held
294KPut Options Held
318K-
Black Rock Inc. New York, NY2.74MShares$106 Million0.0% of portfolio
-
State Street Corp Boston, MA1.96MShares$76.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.69MShares$65.6 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$53.9 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.28MShares$49.5 Million0.03% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $1.03B
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...